Literature DB >> 16000365

Osteonecrosis of the jaw and bisphosphonates.

Brian G M Durie, Michael Katz, John Crowley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16000365     DOI： 10.1056/NEJM200507073530120

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  132 in total

1.  Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.

Authors:  Johannes K-H Meier; Daniel Wolff; Steve Pavletic; Hildegard Greinix; Martin Gosau; Hartmut Bertz; Stefanie J Lee; Anita Lawitschka; Sharon Elad
Journal:  Clin Oral Investig       Date:  2010-09-22       Impact factor: 3.573

Review 2.  A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

Authors:  Cesar Augusto Migliorati; Sook-Bin Woo; Ian Hewson; Andrei Barasch; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-04-22       Impact factor: 3.603

Review 3.  Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Authors:  Sabrina Crépin; Marie-Laure Laroche; Bernard Sarry; Louis Merle
Journal:  Eur J Clin Pharmacol       Date:  2010-05-01       Impact factor: 2.953

4.  Osteonecrosis of the jaw.

Authors:  Catherine Van Poznak
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

5.  Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.

Authors:  Jacques Baillargeon; Yong Fang Kuo; Yu-Li Lin; Gregg S Wilkinson; James S Goodwin
Journal:  Ann Pharmacother       Date:  2011-09-27       Impact factor: 3.154

Review 6.  Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases.

Authors:  O Filleul; E Crompot; S Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

Review 7.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

8.  Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Authors:  Jeanny B Aragon-Ching; Yang-Min Ning; Clara C Chen; Lea Latham; Jean-Pierre Guadagnini; James L Gulley; Philip M Arlen; John J Wright; Howard Parnes; William D Figg; William L Dahut
Journal:  Cancer Invest       Date:  2009-02       Impact factor: 2.176

9.  A prospective study of bone tumor response assessment in metastatic breast cancer.

Authors:  Naoki Hayashi; Colleen M Costelloe; Tsuyoshi Hamaoka; Caimiao Wei; Naoki Niikura; Richard L Theriault; Gabriel N Hortobagyi; John E Madewell; Naoto T Ueno
Journal:  Clin Breast Cancer       Date:  2012-10-24       Impact factor: 3.225

10.  Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases.

Authors:  Annalisa Bramati; Serena Girelli; Gabriella Farina; Maria Chiara Dazzani; Valter Torri; Anna Moretti; Sheila Piva; Mariastella Dimaiuta; Nicla La Verde
Journal:  J Bone Miner Metab       Date:  2014-02-20       Impact factor: 2.626
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.